amifostine (Bedford Laboratories)
Welcome to the PulseAid listing for the amifostine drug offered from Bedford Laboratories. This Cytoprotective Agent [EPC],Free Radical Scavenging Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bedford Laboratories |
| NON-PROPRIETARY NAME: | amifostine |
| SUBSTANCE NAME: | AMIFOSTINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytoprotective Agent [EPC],Free Radical Scavenging Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-04-02 |
| END MARKETING DATE: | 2018-12-31 |
amifostine HUMAN PRESCRIPTION DRUG Details:
| Item Description | amifostine from Bedford Laboratories |
| LABELER NAME: | Bedford Laboratories |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/10mL) |
| START MARKETING DATE: | 2008-04-02 |
| END MARKETING DATE: | 2018-12-31 |
| PRODUCT ID: | 55390-308_5c68e9e1-47b8-4c03-8f8a-60afc67e023e |
| PRODUCT NDC: | 55390-308 |
| APPLICATION NUMBER: | NDA020221 |
Other AMIFOSTINE Pharmaceutical Manufacturers / Labelers:
